Joerger, Markus; https://orcid.org/0000-0001-6602-6287, Metaxas, Yannis, Zaman, Khalil; https://orcid.org/0000-0002-2997-527X, Michielin, Olivier, Mach, Nicolas; https://orcid.org/0000-0001-8944-1088, Bettini, Adrienne, Schmitt, Andreas M; https://orcid.org/0000-0002-9568-8164, Cantoni, Nathan; https://orcid.org/0000-0001-9002-9015, Caspar, Clemens B, Stettler, Sonja, Malval, Roma, Pless, Miklos, Britschgi, Christian, Renner, Christoph, Koeberle, Dieter, Schulz, Jessica D, Kopp, Christoph, Hayoz, Stefanie; https://orcid.org/0000-0002-2265-6559, Stathis, Anastasios, von Moos, Roger, Swiss Group for Clinical Cancer Research (SAKK), Joerger, Markus; https://orcid.org/0000-0001-6602-6287, Metaxas, Yannis, Zaman, Khalil; https://orcid.org/0000-0002-2997-527X, Michielin, Olivier, Mach, Nicolas; https://orcid.org/0000-0001-8944-1088, Bettini, Adrienne, Schmitt, Andreas M; https://orcid.org/0000-0002-9568-8164, Cantoni, Nathan; https://orcid.org/0000-0001-9002-9015, Caspar, Clemens B, Stettler, Sonja, Malval, Roma, Pless, Miklos, Britschgi, Christian, Renner, Christoph, Koeberle, Dieter, Schulz, Jessica D, Kopp, Christoph, Hayoz, Stefanie; https://orcid.org/0000-0002-2265-6559, Stathis, Anastasios, von Moos, Roger, and Swiss Group for Clinical Cancer Research (SAKK)
PURPOSE These are the final results of a national registry on cancer patients with COVID-19 in Switzerland. METHODS We collected data on symptomatic COVID-19-infected cancer patients from 23 Swiss sites over a one-year period starting on 1 March 2020. The main objective was to assess the outcome (i.e., mortality, rate of hospitalization, ICU admission) of COVID-19 infection in cancer patients; the main secondary objective was to define prognostic factors. RESULTS From 455 patients included, 205 patients (45%) had non-curative disease, 241 patients (53%) were hospitalized for COVID-19, 213 (47%) required oxygen, 43 (9%) invasive ventilation and 62 (14%) were admitted to the ICU. Death from COVID-19 infection occurred in 98 patients, resulting in a mortality rate of 21.5%. Age ≥65 years versus <65 years (OR 3.14, p = 0.003), non-curative versus curative disease (OR 2.42, p = 0.012), ICU admission (OR 4.45, p < 0.001) and oxygen requirement (OR 20.28, p < 0.001) were independently associated with increased mortality. CONCLUSIONS We confirmed high COVID-19 severity and mortality in real-world cancer patients during the first and second wave of the pandemic in a country with a decentralized, high-quality, universal-access health care system. COVID-19-associated mortality was particularly high for those of older age in a non-curative disease setting, requiring oxygen or ICU care.